Physician profile
Aaron Smith
NPI 1659650166
$2,940.32
in general payments reported to CMS, 2019-2025
19 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $410 · 2021: $279 · 2022: $609 · 2023: $420 · 2024: $383 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $831.26 | 2019-2025 | Clareon, Rocklatan |
| Abbvie INC. | $442.43 | 2022-2025 | Lumigan, Xen Glaucoma Treatment System, Durysta |
| Glaukos Corporation | $326.40 | 2020-2022 | |
| Mentor Worldwide LLC | $217.71 | 2023-2024 | Mentor Memoryshape Breast Implant, Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $179.95 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $172.03 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $156.77 | 2019-2021 | |
| Genentech USA, INC. | $109.66 | 2022-2024 | Vabysmo |
| Omeros Corporation | $88.83 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $85.75 | 2022-2023 | Vyzulta |
| Rayner Intraocular Lenses Limited | $64.48 | 2022-2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Biotissue Holdings INC. | $53.36 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $41.32 | 2023 | Tecnis Simplicity |
| Rxsight INC | $41.05 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Eyepoint US, INC. | $39.63 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $38.23 | 2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $20.38 | 2024 | Tyrvaya |
| Amgen INC. | $16.11 | 2025 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $14.97 | 2025 | Cirrus Hd-Oct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.